Adams Clinical Harlem — New York, New York

Adams Clinical Harlem is a clinical research site located in New York, New York, United States 10029.

Crixeo Clinical Trials Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Adams Clinical Harlem has participated in 8 clinical trials with 8 currently active.

Therapeutic areas: Generalized Anxiety Disorder, Major Depressive Disorder, Opioid Use Disorder.

Sponsors: Definium Therapeutics US, Inc., Cybin IRL Limited, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adams Clinical Harlem?

Adams Clinical Harlem has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adams Clinical Harlem conducted?

Adams Clinical Harlem has 8 clinical trials on record, with 8 currently active. Their work covers Generalized Anxiety Disorder, Major Depressive Disorder, Opioid Use Disorder.

Is Adams Clinical Harlem accredited by Crixeo Clinical Trials?

Adams Clinical Harlem has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Adams Clinical Harlem?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.